Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001012975-25-000681
Filing Date
2025-10-29
Accepted
2025-10-29 19:22:24
Documents
1
Period of Report
2025-10-27

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 10326
  Complete submission text file 0001012975-25-000681.txt   11907
Mailing Address 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631
Business Address
Burow Kristina (Reporting) CIK: 0001569248 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41802 | Film No.: 251431646

Mailing Address 260 ARSENAL PLACE, SUITE 1 WATERTOWN MA 02472
Business Address 260 ARSENAL PLACE, SUITE 1 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Issuer) CIK: 0001885522 (see all company filings)

EIN.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)